{"url_path":"/sec/mxct/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1287098/0001104659-26-060290-index.html","accession_number":"0001104659-26-060290","cik":"0001287098","ticker":"MXCT","issuer_name":"MAXCYTE, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1287098/0001104659-26-060290-index.html","primary_entity_key":"0001287098","primary_entity_name":"MAXCYTE, INC."},"word_count":449,"has_tables":true,"body_markdown":"**Item 6. Exhibits.**\n\nThe following exhibits are filed with this Quarterly Report, or incorporated by reference into, on Form 10-Q:\n\n**Incorporated by Reference**\n\nExhibit\n\nNumber\n\nDescription\n\nForm\n\nFile No.\n\nExhibit\n\nFiling Date\n\n10.1\n\n​\n\n[MaxCyte, Inc. 2026 Inducement Plan](https://www.sec.gov/Archives/edgar/data/1287098/000110465926043814/tm2611297d1_ex99-1.htm)\n\n​\n\nS-8\n\n​\n\n333-295073\n\n​\n\n99.1\n\n​\n\nApril 15, 2026\n\n31.1\n\n[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mxct-20260331xex31d1.htm)\n\n31.2\n\n[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mxct-20260331xex31d2.htm)\n\n32.1*\n\n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](mxct-20260331xex32d1.htm)\n\n32.2*\n\n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](mxct-20260331xex32d2.htm)\n\n101.INS\n\n​\n\nInline XBRL Instance Document.\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n101.SCH\n\n​\n\nInline XBRL Taxonomy Extension Schema Document\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n101.CAL\n\n​\n\nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n101.DEF\n\n​\n\nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n101.LAB\n\n​\n\nInline XBRL Taxonomy Extension Label Linkbase Document\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n101.PRE\n\n​\n\nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n104\n\n​\n\nCover Page Interactive Data File (formatted as inline XBRL with applicable Taxonomy Extension information contained in Exhibits 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE).\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n*\n\nThis exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in such filing.\n\n​\n\n30\n\n[Table of Contents](#TOC)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n​\n\nMaxCyte, Inc.\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Maher Masoud\n\n​\n\nName:\n\nMaher Masoud\n\n​\n\nTitle:\n\nPresident and Chief Executive Officer (Principal Executive Officer)\n\n​\n\n​\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Parmeet Ahuja\n\n​\n\nName:\n\nParmeet Ahuja\n\n​\n\nTitle:\n\nChief Financial Officer (Principal Financial Officer)\n\n​\n\n​\n\n​\n\n31"}